- Home
- LEGN vs HSIC Comparison
LEGN vs HSIC Comparison
Compare LEGN & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LEGN | HSIC |
|---|---|---|
| Founded | 2014 | 1932 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 8.8B |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | LEGN | HSIC |
|---|---|---|
| Price | $23.08 | $78.97 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 13 |
| Target Price | $69.33 | ★ $75.92 |
| AVG Volume (30 Days) | ★ 2.2M | 1.1M |
| Earning Date | 11-12-2025 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 30.70 |
| EPS | N/A | ★ 3.17 |
| Revenue | $909,045,000.00 | ★ $12,938,000,000.00 |
| Revenue This Year | $68.52 | $5.35 |
| Revenue Next Year | $48.63 | $3.34 |
| P/E Ratio | ★ N/A | $24.66 |
| Revenue Growth | ★ 74.75 | 3.51 |
| 52 Week Low | $20.21 | $60.56 |
| 52 Week High | $45.30 | $82.49 |
Technical Indicators
Market Signals| Indicator | LEGN | HSIC |
|---|---|---|
| Relative Strength Index (RSI) | 46.83 | 67.71 |
| Support Level | $20.21 | $76.60 |
| Resistance Level | $22.07 | $79.44 |
| Average True Range (ATR) | 0.85 | 1.33 |
| MACD | 0.34 | 0.02 |
| Stochastic Oscillator | 93.07 | 82.42 |
Price Performance
Historical ComparisonAbout LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About HSIC Henry Schein Inc.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.